(Q38989346)

8 September 2017

Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer (English)

1 reference

8 September 2017

Qu Zhang

1

1 reference

8 September 2017

Chi Zhang

2

1 reference

8 September 2017

Xi Yang

3

1 reference

8 September 2017

Baixia Yang

4

1 reference

8 September 2017

Jinfeng Wang

5

1 reference

8 September 2017

Yahui Kang

6

1 reference

8 September 2017

Zhongming Wang

7

1 reference

8 September 2017

Defan Li

8

1 reference

8 September 2017

Guanhong Huang

9

1 reference

8 September 2017

Zhaoming Ma

10

1 reference

8 September 2017

Xinchen Sun

11

1 reference

8 September 2017

Jing Cai

12

1 reference

8 September 2017

Guangzhou Tao

13

1 reference

8 September 2017

Shengbin Dai

14

1 reference

8 September 2017

Weidong Mao

15

1 reference

8 September 2017

Jianxin Ma

16

1 reference

8 September 2017

27 May 2014

1 reference

8 September 2017

1 reference

8 September 2017

9

1 reference

8 September 2017

98

1 reference

Association between tumor necrosis factor-alpha gene polymorphisms and prostate cancer risk: a meta-analysis

8 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Factors associated with the survival of prostate cancer patients with rectal involvement

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Retracted: Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and -independent human prostate cancer cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Improving radioresponse through modification of the tumor immunological microenvironment

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Cellular response to tissue hypoxia and its involvement in disease progression

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Hypoxia and drug resistance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Preliminary clinical study of weekly recombinant human endostatin as a hypoxic tumour cell radiosensitiser combined with radiotherapy in the treatment of NSCLC.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051149

Trends in prostate cancer survival in Spain: results from population-based cancer registries

21 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1746-1596-9-98

Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24886405

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1746-1596-9-98

1 reference

Dimensions Publication ID

8 September 2017

1011971440

0 references

Fatcat ID

release_km42oizahzcppagapc4khenyh4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/km42oizahzcppagapc4khenyh4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

8 September 2017

PubMed publication ID

24886405

1 reference